GLP-1 Receptor Agonist Use Associated with a Significantly Lower Short-Term Incidence of Obesity-Associated Cancers Among Obese Individuals Without Diabetes By Ogkologos - July 13, 2026 125 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a large real-world cohort Source RELATED ARTICLESMORE FROM AUTHOR Anito-cel, a d-Domain BCMA CAR T-Cell, Induces Rapid, Deep, and Durable Responses in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma EMA Recommends Granting a Marketing Authorisation for Relacorilant Annual Multicancer Early Detection Test Not Associated with a Lower Incidence Rate of Stage III or IV Cancer After Three Screening Rounds and 12... MOST POPULAR Detecting multiple cancers with a ‘simple’ blood test: Where are we? April 14, 2022 Health inequalities: “We have a moral duty to reduce them” February 15, 2022 PET-2-Guided BrECADD Better Tolerated and More Effective than eBEACOPP in Patients... July 16, 2024 Hockey Fan Dubbed Hero After Saving Equipment Manager’s Life January 9, 2022 Load more HOT NEWS ΚΑΡΚΙΝΟΣ ΧΟΛΗΔΟΧΟΥ ΚΥΣΤΕΩΣ Study Says Exercise Combats Side Effects of Chemo and Other Meds... Dad Gets Tattoo On His Chest To Match Daughter’s Scar So... How Anxiety Impacts People With Cancer and How to Cope
